Title: The blood glucose lowering effect of ethanolic extract of Emblica officinalis fruit in alloxan induced hyperglycaemic rats

Authors: Dr Zubaida Kha, Ferdous Ara, Onayza Yasmeen, Israt Jahan, SharminNahar, Sheikh Nazrul Islam

 DOI: https://dx.doi.org/10.18535/jmscr/v7i7.122

Abstract

Objective: in this study our main goal is to evaluate effect of 500 mg/kg b.w ethanolic extract of Emblica officinalis in alloxan induced hyperglycaemic rats& compare with the anti-diabetic drug Glibenclamide in lowering blood glucose level.

Method: this experimental type of study was conducted at Department of Pharmacology and Therapeutics of Sir Salimullah Medical College in collaboration with Institute of Nutrition & Food Science (INFS) and Department of Pharmaceutical Chemistry of the University of Dhaka from January 2013 to December 2013 where 24 healthy Swiss Albino rats were tested during the study.Data was processed and analyzed.

Result: during the study in normal control group (Group A), the blood glucose levels (mean ± SD) was 5.18 ± 0.14 mmol/L where as the serum glucose concentration in Alloxan treated group (Group B) was 12.35 ± 0.42 mmol/L. Also, the mean ± SD of serum glucose concentration in ethanolic extract group C was 7.7± 0.18 m mol/ L and in Glibenclamide treated group (group D) was 6.4± 0.30 m. mol/L.

Conclusion: from many examination, we can suggest that, the glucose lowering effect of 500mg doses of ethanolic extracts of E.officinalisis almost near effective to that of glibenclamide. So, ethanolic extract of Emblica officinalis may offer an alternate treatment for type II diabetes and its complications.

Keyword: Diabetes mellitus, ethanolic extract, Emblica officinalis.

References

  1. Wild, S., Roglic, G., Green, A. Sicree, R., King, H., (2004). 'Global prevalence of Diabetes: Estimates for the year 2000 & projections for 2030'. Diabetes Care, 27, pp. 1047-1053
  2. Rahim, M.A., Hussain, A., Khan, A.K.A., Sayeed, M.A., All, S.M.K., Vaaler, S., (2007). 'Rising prevalence of type 2 diabetes in rural Bangladesh: A population based study'. Diabetes Research & Clinical practice, 77(2), pp. 300-305
  3. Rajasekaran, S., Ravi, K., Sivagnanam, K. & Subramanian, S., (2006). 'Beneficial effects of Aloevera gel extract on lipid profile status in rats with streptozotocin diabetes'. Clinical & experimental pharmacology & physiology, 33, pp. 232-237.
  4. Nicholas, A., Boon, N.R., Colledge, B.R., Walker, (2004). Davidson's Principles & Practice of Medicine, 22nd Edition, pp. 812-815 available at http://secure-ecsd.elsevier.com/uk/files/med/22kevpoints abouthe22edition.pdf
  5. Chopra, R.N, Chopra, I.C., Handa, L.L. & Kapur, L.D, (1982). 'Chopra's indigenous drugs of India 2nd edition'. Academic publishers, 605,673,682,688
  6. Daisy, P.H.I., Averal & Modilal, R.D., (2004). 'Curative properties of phyllanthus extracts in alloxan induced diabetic rats'. Trop. Med. plants, 5, pp.21-27
  7. Halluwell, B., Gullerdge, J.M.C. & Cross, E.S., (1992). 'Free radicals & human disease: Where are we now'?, Lab. Clin. Med, 119, pp.598-620
  8. Krishnaveni, Mani, Sankaran Mirunalini, Kandan Karthishwaran, and Ganesan Dhamodharan. "Antidiabetic and antihyperlipidemic properties of Phyllanthus emblicaLinn. (Euphorbiaceae) on streptozotocin induced diabetic rats." Pak J Nutr 9, no. 1 (2010): 43-51.
  9. Twaij, H.A.A. and A.A. Al-Badr, 1988. Hypoglycemic activity of Artemisiaherba alba . J. Ethnopharmacol.,24: 123-126.

Corresponding Author

Dr Zubaida Kha

Medical Officer, Department of Pharmacology, Sir Salimullah Medical College and Mitford Hospital, Dhaka